Transforming Health and Healing is both the vision and the promise of the Woodruff Health Sciences Center. It means pioneering discoveries that advance our understanding of disease prevention and treatment, preparing the next generation of health professionals to save and improve lives in communities worldwide, and continuously improving the quality of care for our patients. Some of the recent accomplishments made possible by our collaborators, trustees, donors, and friends include the following:

• Emory School of Medicine opened a new, state-of-the-art education building that enabled inauguration of a completely revamped medical curriculum.
• We recently expanded our work in clinical trials to increase access to new treatments. These efforts received a major boost from a $31 million NIH grant to help us create a clinical research partnership with Morehouse School of Medicine, Georgia Tech, and Children’s Healthcare of Atlanta. In cancer, we worked with community partners to implement the first state-wide clinical trial for patients with breast cancer. Meanwhile, early-stage clinical trials of an AIDS vaccine developed at Yerkes National Primate Research Center and the Emory Vaccine Center are under way.
• In its first year of existence, Emory’s Global Health Institute helped fund eight projects in low-resource countries, ranging from a drug discovery program in South Africa to a diabetes intervention in India.
• The Center for Health Discovery and Well-Being, part of the Emory/Georgia Tech Predictive Health Institute, opened at our midtown campus to provide participants personalized health programs designed to address individual health risks.
• Nell Hodgson Woodruff School of Nursing was one of 15 nursing schools in the nation tapped by the Robert Wood Johnson Foundation to develop quality and safety education curricula as part of a new model for nursing education.
• With a recent $50 million investment from its family namesake, Rollins School of Public Health will break ground this spring on a complex that will double its current space and accelerate teaching and research in global and predictive health, infectious disease, nutrition, cancer, and diabetes.
• Emory Healthcare physicians provided $53.6 million in charity care last year.

A glimpse at these milestones and others will show how we are bringing to reality our vision to transform health and healing.

Fred Sanfilippo, MD, PhD
Executive Vice President for Health Affairs
CEO, Woodruff Health Sciences Center
Chairman, Emory Healthcare

Video Address

On Oct. 1, 2007, Fred Sanfilippo, MD, PhD, began as chief of the health sciences at Emory University. He is Emory University Executive Vice President for Health Affairs, CEO of Emory's Woodruff Health Sciences Center and Chairman of Emory Healthcare.

On day one, Dr. Sanfilippo met with members of the Woodruff Health Sciences Center and the Atlanta community to present his first thoughts about leading the center in the years ahead.

Dr. Sanfilippo's Remarks*
or Entire Presentation
with Introduction by Emory President James Wagner
and Question & Answer Session

* Requires need RealNetworks RealPlayer plug-in.

Transforming Health and Healing

Find out from Dr. Fred Sanfilippo what "transforming health and healing" reallys means:

"Vision for the future," 2/11/08

More About Dr. Sanfilippo

Fred Sanfilippo, MD, PhD, is Emory University Executive Vice President for Health Affairs, CEO of Emory's Woodruff Health Sciences Center and Chairman of Emory Healthcare. His tenure at Emory began Oct. 1, 2007. The Woodruff Health Sciences Center includes the Emory University School of Medicine, Nell Hodgson Woodruff School of Nursing, Rollins School of Public Health, Yerkes National Primate Research Center, and Emory Healthcare, the WHSC's system of clinical facilities.

Dr. Sanfilippo joined Emory after serving The Ohio State University as Senior Vice President for Health Sciences, Dean of the College of Medicine and Medical Center CEO at The Ohio State University, beginning in September 2000, and as Executive Dean for Health Sciences beginning in April 2004. From 1993 to 2000, Dr. Sanfilippo was the Baxley Professor and Chair of the Department of Pathology at Johns Hopkins. He led the formation of the Johns Hopkins Comprehensive Transplant Center, serving as its first Director of Research. He joined the Duke faculty in 1979, where he ultimately served as Professor of Pathology, Surgery, and Immunology, director of the Immunogenetics-Transplantation Laboratory, and chief of the renal and transplant pathology services.

With over 250 publications and $20 million in personal research grant support, Dr. Sanfilippo has been an active leader in transplantation, pathology and academic medicine. He has served on the editorial board of 13 professional journals, has been elected president of seven academic and professional organizations, and received numerous awards and recognition. National leadership roles include the Association of Academic Health Centers Board of Directors and Chair of the Council on Research and Science and the American Association of Medical Colleges Institute for Improvement of Clinical Care Advisory Board. Dr. Sanfilippo received his BS and MS degrees in physics from the University of Pennsylvania in 1970, and his MD and PhD in immunology as a Medical Scientist Training Program Fellow at Duke University.